ANI PHARMACEUTICALS, INC Indefinite-lived Intangible Assets Acquired
ANI PHARMACEUTICALS, INC (ANIP) reported Indefinite-lived Intangible Assets Acquired of -$34.63 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Notes › Goodwill and Other
us-gaap:IndefinitelivedIntangibleAssetsAcquired · last filed 2014-11-10
- ANI PHARMACEUTICALS, INC indefinite-lived intangible assets acquired for the quarter ending 2014-09-30 was -$22.12M.
- ANI PHARMACEUTICALS, INC indefinite-lived intangible assets acquired for the quarter ending 2014-06-30 was $0.00.
- ANI PHARMACEUTICALS, INC indefinite-lived intangible assets acquired for the quarter ending 2014-03-31 was -$12.52M.
- ANI PHARMACEUTICALS, INC indefinite-lived intangible assets acquired for the quarter ending 2013-09-30 was $0.00.
| Period end | Indefinite-lived Intangible Assets Acquired 3 month | Indefinite-lived Intangible Assets Acquired 6 month | Indefinite-lived Intangible Assets Acquired 9 month |
|---|---|---|---|
| 2014-09-30 | -$22.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$22.12M derived: sum of 2 quarters · filed 2014-11-10 | -$34.63M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$12.52M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$12.52M 10-Q · filed 2014-05-12 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |